BioHarvest Sciences (BHST) to Release Quarterly Earnings on Monday

BioHarvest Sciences (NASDAQ:BHST) is projected to issue its quarterly earnings data before the market opens on Monday, March 31st. Analysts expect the company to announce earnings of ($0.12) per share and revenue of $7.24 million for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

BioHarvest Sciences Trading Up 1.6 %

Shares of NASDAQ BHST opened at $6.55 on Friday. The firm has a market cap of $107.58 million, a P/E ratio of -5.24 and a beta of 2.27. BioHarvest Sciences has a 12-month low of $6.53 and a 12-month high of $7.38. The firm has a fifty day moving average of $5.65.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Maxim Group started coverage on shares of BioHarvest Sciences in a report on Wednesday, December 18th. They set a “buy” rating and a $12.00 price objective for the company. HC Wainwright started coverage on shares of BioHarvest Sciences in a research report on Friday, December 6th. They issued a “buy” rating and a $14.00 target price for the company.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.